(Q26823847)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676441%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Antônio Lúcio Teixeira-Júnior

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676441%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Antônio Emanuel dos Santos

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676441%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Bruno Dubois

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676441%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

1 reference

March 2014

1 reference

Arquivos de Neuro-Psiquiatria

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676441%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

72

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676441%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676441%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

227-231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676441%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

The worldwide societal costs of dementia: Estimates for 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Immunotherapy in Alzheimer's disease: do we have all the pieces of the puzzle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Diagnosis and biomarkers of predementia in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Amyloid imaging in the prediction of Alzheimer-type dementia in subjects with amnestic MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Revising the definition of Alzheimer's disease: a new lexicon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

CSF biomarkers predict rate of cognitive decline in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

CSF biomarkers predict a more malignant outcome in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

CSF biomarkers in relationship to cognitive profiles in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

CSF tau markers are correlated with hippocampal volume in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

CSF biomarkers in frontotemporal lobar degeneration with known pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Diagnostic value of CSF biomarker profile in frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Focal cortical presentations of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Neural correlates of cognitive impairment in posterior cortical atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Clinicopathologic differences among patients with behavioral variant frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Progressive posterior cortical dysfunction: a clinicopathologic series

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Prediction of pathology in primary progressive language and speech disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Distinct brain perfusion pattern associated with CSF biomarkers profile in primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Subtypes of progressive aphasia: application of the International Consensus Criteria and validation using β-amyloid imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Classification of primary progressive aphasia and its variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Frontal presentation of Alzheimer's disease: a series of patients with biological evidence by CSF biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

Primary progressive aphasia and the growing role of biomarkers in neurological diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

inferred from DOI database lookup

7 January 2021

based on heuristic

The paradox of syndromic diversity in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

inferred from DOI database lookup

7 January 2021

based on heuristic

The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation study.

1 reference

https://api.crossref.org/works/10.1590%2F0004-282X20130233

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1590/0004-282X20130233

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676441%20AND%20SRC:MED&resulttype=core&format=json

release_i3sbckm55nd6rihr2zhwsi2geu

11 June 2020

Fatcat ID

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24676441%20AND%20SRC:MED&resulttype=core&format=json